Moleculin BiotechMBRX
13F holders, Q2 2025 (June 30)22holders −1
4new positions
4sold out
$0.30avg. 13F price*
At the end of Q2 2025, 22 institutions reported holding Moleculin Biotech Inc. (MBRX) in their 13F filings, down 1 from Q1 2025. 4 opened new positions and 4 sold out. The largest holders were Citigroup Inc. ($26K), XTX Topco Ltd ($22K) and Virtu Financial LLC ($18K).
- Company
- Moleculin Biotech Inc.
- CUSIP
- 60855D309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $22K |
| Exits | 4 | $1.3M |
All 13F filers, Q1 2025 → Q2 2025: 231,743 shares bought and 1,320,378 shares sold, net −1,088,635 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Citigroup Inc. | 0.00% | Add +2958.9% | 85,283 | $26K |
| XTX Topco Ltd | 0.00% | Add +541.2% | 74,217 | $22K |
| Virtu Financial LLC | 0.00% | New | 59,278 | $18K |
| LPL Financial LLC | 0.00% | Add +21.7% | 56,080 | $17K |
| Vanguard Group Inc. | 0.00% | No change | 30,935 | $9K |
| Geode Capital Management, LLC | 0.00% | Add +5.7% | 27,530 | $8K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 12,781 | $4K |
| BlackRock, Inc. | 0.00% | No change | 12,380 | $4K |
| Truist Financial Corp. | 0.00% | No change | 10,500 | $3K |
| UBS Group AG | 0.00% | New | 7,989 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +190.9% | 3,921 | $1K |
| Stone House Investment Management, LLC | 0.00% | New | 3,300 | $996 |
| NFSG Corp | 0.00% | Add +109.7% | 2,867 | $866 |
| Morgan Stanley | 0.00% | No change | 926 | $280 |
| SBI Securities Co., Ltd. | 0.00% | No change | 746 | $225 |
| Atlantic Union Bankshares Corp | 0.00% | New | 379 | $115 |
| Bogart Wealth, LLC | 0.00% | No change | 300 | $91 |
| Bank of America Corp. | 0.00% | Add +356.3% | 146 | $44 |
| Osaic Holdings, Inc. | 0.00% | No change | 43 | $12 |
| CVA Family Office, LLC | 0.00% | No change | 34 | $10 |
| North Star Investment Management Corp. | 0.00% | No change | 17 | $5 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is MBRX's weight in each manager's 13F, not the share of Moleculin Biotech Inc. the manager owns.